Remdesivir Didn't Cut Hospital Stay Or Mortality In Covid Patients: WHO
Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
Comments
Post a Comment